Results 151 to 160 of about 27,579 (221)

The landscape of cellular immune alteration in systemic lupus erythematosus. [PDF]

Front Immunol
Xiao J, Duan L, Yang J, Deng Y, Pang S, Wang H, Yin X, Wang H, Qiu Y, Li X, Gong Y, Li H.   +11 more
europepmc   +1 more source

Chronic Urticaria and Malignancy: A Review Uncovering the Common Links. [PDF]

Biomedicines
Lekli E, Hoxha M, Bova M, Gjonbrataj J, Mati K, Vyshka G, Qirko E.   +6 more
europepmc   +1 more source

PhIP-Seq: unveiling the complexity of antibody repertoires in health and disease. [PDF]

Front Immunol
Tang W, Gai Q, Yang J, Chen J, Lyu Z.
europepmc   +1 more source

The rheumatoid arthritis citrullinome is enriched in antigenic complement proteins. [PDF]

Arthritis Res Ther
Navarrete M, Trivedi K, Klenke C, Zheng Z, Kim J, Atkia Maisha J, Semenenko A, Meng X, Okeke OI, Munoz-Grajales C, Peschken C, Shelef MA, El-Gabalawy HS, O'Neil LJ.   +13 more
europepmc   +1 more source

Multiple sclerosis and autoimmunity: a reappraisal of the evidence. [PDF]

Front Immunol
Amigo M, Sen MK, Dunn JS, Mahns DA.
europepmc   +1 more source

Cellular Immunotherapies for Multiple Sclerosis: Mechanistic Insights and Clinical Advances. [PDF]

Int J Mol Sci
Kurilin V, Fisher M, Obleukhova I, Sennikov S.   +3 more
europepmc   +1 more source

Detection of Diagnostic Antibodies in Immune-Mediated Diseases: A Focus on Antigens and Technologies. [PDF]

Chembiochem
Bracci S, Real-Fernandez F, Pratesi F, Nuti F, Rovero P, Papini AM.   +5 more
europepmc   +1 more source

T-cell mechanisms in atopic dermatitis. [PDF]

Allergol Select
Baumann PC, Roesner LM.
europepmc   +1 more source

Differentiating naturally occurring and disease associated autoantibodies in MPO-ANCA vasculitis through immunogenomic and epitope comparisons. [PDF]

Front Med (Lausanne)
Chen DP, Moon YH, Peck BA, Taylor JJ, Gomez-Martinez I, Woodcock MG, Vincent BG, Falk RJ, Poulton JS, Bunch DO.   +9 more
europepmc   +1 more source

Preclinical characterization of AZD1163, a first-in-class anti-PAD2/4 bispecific antibody for the treatment of rheumatoid arthritis. [PDF]

MAbs
Sims GP, Scaletta L, Andrews J, Sims DA, Strain M, Sigurdardottir A, Kuriakose T, England E, Rajasinghe L, Jiang F, Xiong X, Neal F, Vinall L, Newton P, Boger E, Kim C, Dahlbäck H, Prothon S, Leander J, Darrah E, Collins M, Douglas G, White N, Day K, Vousden KA, Huntington CE, Close D.   +26 more
europepmc   +1 more source